Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry J M Groen

Showing results (131-140 of 274) with videos related to

Pageof 28
Sort By:
Journal of the National Cancer Center|July 22, 2024
Cost-effectiveness of lung cancer screening by low-dose CT in China: a micro-simulation studyYihui Du, Yanju Li, Grigory Sidorenkov, et al.
The European Respiratory Journal|November 7, 2015
Clinical features of large cell neuroendocrine carcinoma: a population-based overviewJules L Derks, Lizza E Hendriks, Wieneke A Buikhuisen, et al.
Cancers|May 17, 2020
Comparison of Circulating Cell-Free DNA Extraction Methods for Downstream Analysis in Cancer PatientsPaul van der Leest, Pieter A Boonstra, Arja Ter Elst, et al.
Cancer Discovery|July 31, 2014
Dual inhibition of EGFR with afatinib and cetuximab in kinase inhibitor-resistant EGFR-mutant lung cancer with and without T790M mutationsYelena Y Janjigian, Egbert F Smit, Harry J M Groen, et al.
JCO Clinical Cancer Informatics|May 19, 2021
Development and Evaluation of a Real-World Outcomes-Based Tool to Support Informed Clinical Decision Making in the Palliative Treatment of Patients With Metastatic NSCLCChristine M Cramer-van der Welle, Elisabeth A Kastelijn, Bram C Plouvier, et al.
International Journal of Cancer|July 12, 2025
Stage- and histology-specific sensitivity for the detection of lung cancer of the NELSON screening protocol-A modeling studyKoen de Nijs, Kevin Ten Haaf, Juul Hubert, et al.
Scientific Reports|March 19, 2021
Real-world outcomes versus clinical trial results of immunotherapy in stage IV non-small cell lung cancer (NSCLC) in the NetherlandsChristine M Cramer-van der Welle, Marjon V Verschueren, Merel Tonn, et al.
Pharmacoepidemiology and Drug Safety|December 9, 2020
Systematic evaluation of the efficacy-effectiveness gap of systemic treatments in extensive disease small cell lung cancerChristine M Cramer-van der Welle, Franz M N H Schramel, Bas J M Peters, et al.
American Journal of Respiratory and Critical Care Medicine|December 17, 2009
The 15q24/25 susceptibility variant for lung cancer and chronic obstructive pulmonary disease is associated with emphysemaDiether Lambrechts, Ian Buysschaert, Pieter Zanen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 31, 2011
The role of the ¹⁸f-fluorodeoxyglucose-positron emission tomography scan in the Nederlands Leuvens Longkanker screenings Onderzoek lung cancer screening trialSusan C van't Westeinde, Harry J de Koning, Frederik B Thunnissen, et al.
Pageof 28

Showing results (131-140 of 274) with videos related to

Sort By:
Pageof 28
Journal of the National Cancer Center|July 22, 2024
Cost-effectiveness of lung cancer screening by low-dose CT in China: a micro-simulation studyYihui Du, Yanju Li, Grigory Sidorenkov, et al.
The European Respiratory Journal|November 7, 2015
Clinical features of large cell neuroendocrine carcinoma: a population-based overviewJules L Derks, Lizza E Hendriks, Wieneke A Buikhuisen, et al.
Cancers|May 17, 2020
Comparison of Circulating Cell-Free DNA Extraction Methods for Downstream Analysis in Cancer PatientsPaul van der Leest, Pieter A Boonstra, Arja Ter Elst, et al.
Cancer Discovery|July 31, 2014
Dual inhibition of EGFR with afatinib and cetuximab in kinase inhibitor-resistant EGFR-mutant lung cancer with and without T790M mutationsYelena Y Janjigian, Egbert F Smit, Harry J M Groen, et al.
JCO Clinical Cancer Informatics|May 19, 2021
Development and Evaluation of a Real-World Outcomes-Based Tool to Support Informed Clinical Decision Making in the Palliative Treatment of Patients With Metastatic NSCLCChristine M Cramer-van der Welle, Elisabeth A Kastelijn, Bram C Plouvier, et al.
International Journal of Cancer|July 12, 2025
Stage- and histology-specific sensitivity for the detection of lung cancer of the NELSON screening protocol-A modeling studyKoen de Nijs, Kevin Ten Haaf, Juul Hubert, et al.
Scientific Reports|March 19, 2021
Real-world outcomes versus clinical trial results of immunotherapy in stage IV non-small cell lung cancer (NSCLC) in the NetherlandsChristine M Cramer-van der Welle, Marjon V Verschueren, Merel Tonn, et al.
Pharmacoepidemiology and Drug Safety|December 9, 2020
Systematic evaluation of the efficacy-effectiveness gap of systemic treatments in extensive disease small cell lung cancerChristine M Cramer-van der Welle, Franz M N H Schramel, Bas J M Peters, et al.
American Journal of Respiratory and Critical Care Medicine|December 17, 2009
The 15q24/25 susceptibility variant for lung cancer and chronic obstructive pulmonary disease is associated with emphysemaDiether Lambrechts, Ian Buysschaert, Pieter Zanen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 31, 2011
The role of the ¹⁸f-fluorodeoxyglucose-positron emission tomography scan in the Nederlands Leuvens Longkanker screenings Onderzoek lung cancer screening trialSusan C van't Westeinde, Harry J de Koning, Frederik B Thunnissen, et al.
Pageof 28